Amgen has completed its first next-gen biomanufacturing facility in Singapore encompassing multiple technologies aimed at enabling greater speed, productivity and flexibility in commercial-scale manufacturing.   The new Taus facility uses single-use bioreactors, disposable plastic containers, continuous purification processing and real-time quality analysis, and, according to the company, was completed in half the time required for conventional biomanufacturing plants. This flexible, modular des...